ANALYST-UPGRADE ·Filed Oct 16, 2026

IMNM

Immunome Inc.
BULLISH
Impact 4/10
Processed2d 15h ago SECanalyst-IMNM-williamb-20261016
William Blair initiates coverage on IMNM at Outperform

Price Chart

Loading chart...

Executive Summary

William Blair initiates coverage on IMNM at Outperform

Impact Score

Base Score
1/7
LLM Adjustment
+0
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
19 (95%)
Hold
1
Sell / Strong Sell
0
Total Analysts
15
Mean PT
$35.20
Median PT
$36.00
High PT
$40.00
Low PT
$24.00
Current Price
$17.50
Implied Upside
+101.2%

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-10-16William BlairinitiateOutperform—
2026-10-01StifelinitiateHold$24.00
2026-09-21Alliance Global PartnersinitiateBuy$32.00
2026-09-10HC Wainwright & Co.reiterateBuy$40.00
2026-08-12Truist SecuritiesmaintainBuy$38.00
2026-08-12WedbushmaintainOutperform$35.00
2026-07-21WedbushreiterateOutperform$31.00
2026-06-12WedbushreiterateOutperform$31.00
2026-05-28Truist SecuritiesmaintainBuy$37.00
2026-05-28BarclaysinitiateOverweight$36.00

Firm Track Record — William Blair

William Blair accuracy: 51% on 273 calls | avg return: 4.2%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 7 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
JP Morgan100%2/232.2%top tier
Stephens & Co.67%2/33.3%top tier
Evercore ISI Group50%1/233.3%below average
Lake Street50%1/27.7%below average
Guggenheim50%2/411.8%below average
Piper Sandler33%1/3-6.5%below average
Wedbush25%1/4-19%below average

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
+1y$-2.43$-2.90 — $-1.85$53.9M↑1 ↓0
0q$-0.59$-0.71 — $-0.41$142.9K↑3 ↓0
+1q$-0.61$-0.75 — $-0.38$142.9K↑2 ↓0
0y$-2.29$-2.56 — $-2.02$285.7K↑0 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
CITADEL ADVISORS LLC — doubled (179.4%)
Institutional
Jump Financial, LLC — trim (-59.7%)
Institutional
Jefferies Financial Group Inc. — exit (-100%)
Short Interest
Short: 748,527 | Exempt: 144 | TRF Vol: 1,023,728 | Short Ratio: 73.1% | Off-exchange volume (dark pool + OTC)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

14 reports for IMNM
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 16, 2026
2d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$17.40 awaiting T+5awaiting T+5—$16.47 (−5.34%)
Oct 1, 2026
17d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$20.89 $19.31▼ −7.56%▼ −8.86%$16.47 (−21.16%)
Sep 21, 2026
27d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$16.47 (−34.30%)
Aug 12, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$16.47 (−37.66%)
Aug 10, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$16.47 (−37.26%)
Jul 9, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$16.47 (−29.46%)
Jul 7, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$16.47 (−31.40%)
Jul 7, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$16.47 (−31.40%)
Jul 3, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$16.47 (+30.24%)
May 28, 2026
20w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$16.47 (−26.93%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Oct 16, 2026